Akagera Medicines, Inc. (www.akageramedicines.com). Akagera Medicines is developing novel liposomal formulations of antibacterial drugs to treat tuberculosis, as well as developing novel mRNA vaccine candidates against neglected infectious diseases. The company was founded in 2018 in Kigali, Rwanda. It is well-funded, majority-owned by the people of Rwanda, incorporated as a Delaware corporation, and has research laboratories in Boston and San Fr...
